This new research, International Natural Procreative Technology Evaluation and Surveillance of Treatment for Sub-fertility (iNEST) : enrollment and methods sponsored by the IIRRM, and involving multiple IIRRM members, was published earlier this year. “iNEST” worked to establish and build more robust outcomes research for Restorative Reproductive Medicine, and was the first multi-clinic multinational study published for Restorative Reproductive Medicine (and specifically for NaProTechnology). Dr. Joseph Stanford presents this work alongside some of the co-authors involved in the study.
Dr. Paul Carpentier provides an update and review on the use of Lisinopril for Male infertility, discussing the article, “Angiotensin-converting enzymes play a dominant role infertility”. The biochemistry background of angiotensin-converting enzymes (ACEs) in Male Fertility is also reviewed, with discussion following.
“Is B-cell CLL/lymphoma 6 (BCL6) endometrial expression, a surrogate biomarker of endometriosis, elevated in women with unexplained recurrent pregnancy loss (uRPL) and unexplained infertility (UI) compared to fertile subjects?”. What could this study suggest for potential treatment and future investigations for recurrent miscarriage and unexplained pregnancy loss? Review the findings of this study in the IIRRM Journal club with Dr. Joe Stanford.
In our last Journal club of 2021 Dr Stanford facilitates and reviews the article, Early pregnancy ultrasound measurements and prediction of first-trimester pregnancy loss: A logistic model. The authors suggest a statistical model for determining the likelihood of first-trimester pregnancy loss based on ultrasound markers in early pregnancy.
Review the findings with Dr Joseph Stanford, of a population-based cohort study examining the impact of celiac disease on women’s reproductive health from Grode et. al.1 in October’s Journal club. “How does celiac disease (CD) influence women’s reproductive life, both prior to and after the diagnosis?” – Download the article before viewing the webinar.
Dr. Keenan discuss vaccine safety in pregnancy, looking article reporting preliminary data on the safety of messenger RNA (mRNA) Covid-19 vaccines in pregnancy taken from the v-safe surveillance system and pregnancy registry. Oppotunrity to comment and share articles in the RRM Forum.
Dr. Carpentier shares his experience with and looks into the science behind the use of dexamphetamine treatment as a novel off-label treatment for a number of female chronic disorders that do not respond well to conventional therapy including recurrent pregnancy loss, inflammation, and ongoing pain. The primary article of focus for this journal club, “The neurotransmitter dopamine modulates vascular permeability in the endothelium”, along with a list of references can be downloaded to accompany the webinar.
Men are consistently overrepresented in severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection, and coronavirus disease 2019 (COVID-19) severe outcomes, including higher fatality rates. This journal club examines a review that sought to summarize the available literature regarding proposed molecular and cellular markers of COVID-19 infection, their associations with health outcomes, and any reported modification by sex.
This Journal club presented by Dr. Mary Davenport, looks at the article by Contreras P. et. al , “Simple and Improved Predictor of Insulin Resistance Extracted From the Oral Glucose Tolerance Test: The I0*G60”. Dr. Davenport is a FertilityCare Medical Consultant and a Fellow of the RHRI, with a master’s degree in nutrition and metabolism, which informs her integrative approach to women’s health care, and is a private practice OBGYN in the San Francisco, USA area.